United States Pharmaceuticals

Tolmar Therapeutics Inc (atrx)

Track

Ticker: atrx
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
DUNCAN MICHAEL R VP and General Manager Officer
Transaction date
Planned sale
Price
127.11
Quantity 14,637 +9.6%
Value US$1,460,865
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Planned sale
Price
216.25
Quantity 59,171 +22.5%
Value US$2,563,484
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Planned sale
Price
340.15
Quantity 147 +12.2%
Value US$2,416,081
DUNCAN MICHAEL R VP and General Manager
Transaction date
Planned sale
Price
30.14
Quantity 800 -52.8%
Value US$24,108
DUNCAN MICHAEL R VP and General Manager
Transaction date
Planned sale
Price
30.14
Quantity 4,200 -85.5%
Value US$126,567
GARRETT J STEVEN Senior VP Clinical Research
Transaction date
Planned sale
Price
30.39
Quantity 1,200 -24.7%
Value US$36,468
GARRETT J STEVEN Senior VP Clinical Research
Transaction date
Planned sale
Price
30.39
Quantity 3,800 -43.8%
Value US$115,482
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Planned sale
Price
32.02
Quantity 10,000 -6.4%
Value US$320,190
DUNCAN MICHAEL R VP and General Manager Officer
Transaction date
Planned sale
Price
30.12
Quantity 3,300 -85.7%
Value US$99,396
DUNCAN MICHAEL R VP and General Manager Officer
Transaction date
Planned sale
Price
30.12
Quantity 1,700 -75.6%
Value US$51,204
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Planned sale
Price
30.00
Quantity 5,000 -58.8%
Value US$150,000
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Planned sale
Price
29.21
Quantity 10,000 -6.4%
Value US$292,100
DUNCAN MICHAEL R VP and General Manager Officer
Transaction date
Planned sale
Price
30.11
Quantity 1,000 -64.5%
Value US$30,110
DUNCAN MICHAEL R VP and General Manager Officer
Transaction date
Planned sale
Price
30.11
Quantity 4,000 -87.9%
Value US$120,440
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Planned sale
Price
30.53
Quantity 5,000 -58.8%
Value US$152,650
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Planned sale
Price
30.57
Quantity 10,000 -6.4%
Value US$305,700
WARREN STEPHEN L VP R&D and CSO
Transaction date
Planned sale
Price
33.50
Quantity 5,000 -100.0%
Value US$167,500
DUNCAN MICHAEL R VP and General Manager
Transaction date
Sale
Price
33.50
Quantity 7,000 -92.7%
Value US$234,500
GARRETT J STEVEN Senior VP Clinical Research
Transaction date
Planned sale
Price
31.96
Quantity 5,000 -41.3%
Value US$159,775
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Planned sale
Price
33.04
Quantity 10,000 -6.4%
Value US$330,400
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Planned sale
Price
32.77
Quantity 1,200 -14.5%
Value US$39,324
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Planned sale
Price
32.77
Quantity 3,800 -34.9%
Value US$124,526
BETHUNE DAVID R CEO/Chairman Executive Director
Transaction date
Sale
Price
28.50
Quantity 10,000 -6.4%
Value US$284,950
GARRETT J STEVEN Senior VP Clinical Research
Transaction date
Sale
Price
27.02
Quantity 2,000 -15.5%
Value US$54,030
BETHUNE DAVID R Chief Executive Officer Executive Director
Transaction date
Sale
Price
31.16
Quantity 10,000 -6.4%
Value US$311,620
GARRETT J STEVEN Sr VP Clincal Research Officer
Transaction date
Sale
Price
29.26
Quantity 2,000 -13.4%
Value US$58,520
BETHUNE DAVID R Chairman and CEO Executive Director
Transaction date
Sale
Price
26.34
Quantity 10,000 -6.4%
Value US$263,410
VUTURO GEORGE J Non-Executive Director
Transaction date
Purchase
Price
24.53
Quantity 10,000 +61.2%
Value US$245,300
YARBOROUGH CODY L VP Dermatology Division Officer
Transaction date
Sale
Price
24.80
Quantity 900 -81.8%
Value US$22,320
YARBOROUGH CODY L VP Dermatology Division Officer
Transaction date
Sale
Price
25.00
Quantity 500 -31.2%
Value US$12,500
GARRETT J STEVEN Sr VP Clinical Research Officer
Transaction date
Sale
Price
24.26
Quantity 1,500 -10.4%
Value US$36,390
YARBOROUGH CODY L VP Dermatology Division Officer
Transaction date
Sale
Price
25.23
Quantity 500 -71.4%
Value US$12,615
YARBOROUGH CODY L VP Dermatology Division
Transaction date
Sale
Price
26.90
Quantity 500 -71.4%
Value US$13,450
GARRETT J STEVEN Sr VP Clinical Research
Transaction date
Sale
Price
26.90
Quantity 2,000 -12.2%
Value US$53,800
GARRETT J STEVEN Senior VP Clinical Research Officer
Transaction date
Sale
Price
25.05
Quantity 2,000 -10.9%
Value US$50,100
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2004-11-16 2004-11-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
14,637 +9.6%
127.11
US$1,460,865 		14,637 +9.6% 127.11 US$1,460,865
2004-11-12 2004-11-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
59,171 +22.5%
216.25
US$2,563,484 		59,171 +22.5% 216.25 US$2,563,484
2004-11-08 2004-11-05 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
147 +12.2%
340.15
US$2,416,081 		147 +12.2% 340.15 US$2,416,081
2004-10-19 2004-10-18 PlS Planned sale
DUNCAN MICHAEL R

VP and General Manager
800 -52.8%
30.14
US$24,108 		800 -52.8% 30.14 US$24,108
2004-10-19 2004-10-18 PlS Planned sale
DUNCAN MICHAEL R

VP and General Manager
4,200 -85.5%
30.14
US$126,567 		4,200 -85.5% 30.14 US$126,567
2004-10-12 2004-10-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research
1,200 -24.7%
30.39
US$36,468 		1,200 -24.7% 30.39 US$36,468
2004-10-12 2004-10-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research
3,800 -43.8%
30.39
US$115,482 		3,800 -43.8% 30.39 US$115,482
2004-10-06 2004-10-05 PlS Planned sale
BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
32.02
US$320,190 		10,000 -6.4% 32.02 US$320,190
2004-09-16 2004-09-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
3,300 -85.7%
30.12
US$99,396 		3,300 -85.7% 30.12 US$99,396
2004-09-16 2004-09-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
1,700 -75.6%
30.12
US$51,204 		1,700 -75.6% 30.12 US$51,204
2004-09-14 2004-09-13 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
5,000 -58.8%
30.00
US$150,000 		5,000 -58.8% 30.00 US$150,000
2004-09-08 2004-09-07 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
29.21
US$292,100 		10,000 -6.4% 29.21 US$292,100
2004-08-16 2004-08-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
1,000 -64.5%
30.11
US$30,110 		1,000 -64.5% 30.11 US$30,110
2004-08-16 2004-08-16 PlS Planned sale DUNCAN MICHAEL R

VP and General Manager

Officer
4,000 -87.9%
30.11
US$120,440 		4,000 -87.9% 30.11 US$120,440
2004-08-11 2004-08-11 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
5,000 -58.8%
30.53
US$152,650 		5,000 -58.8% 30.53 US$152,650
2004-08-05 2004-08-05 PlS Planned sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
30.57
US$305,700 		10,000 -6.4% 30.57 US$305,700
2004-07-19 2004-07-19 PlS Planned sale
WARREN STEPHEN L

VP R&D and CSO
5,000 -100.0%
33.50
US$167,500 		5,000 -100.0% 33.50 US$167,500
2004-07-19 2004-07-16 S Sale
DUNCAN MICHAEL R

VP and General Manager
7,000 -92.7%
33.50
US$234,500 		7,000 -92.7% 33.50 US$234,500
2004-07-12 2004-07-12 PlS Planned sale
GARRETT J STEVEN

Senior VP Clinical Research
5,000 -41.3%
31.96
US$159,775 		5,000 -41.3% 31.96 US$159,775
2004-07-06 2004-07-06 PlS Planned sale
BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
33.04
US$330,400 		10,000 -6.4% 33.04 US$330,400
2004-06-16 2004-06-16 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
1,200 -14.5%
32.77
US$39,324 		1,200 -14.5% 32.77 US$39,324
2004-06-16 2004-06-16 PlS Planned sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
3,800 -34.9%
32.77
US$124,526 		3,800 -34.9% 32.77 US$124,526
2004-06-08 2004-06-07 S Sale BETHUNE DAVID R

CEO/Chairman

Executive Director
10,000 -6.4%
28.50
US$284,950 		10,000 -6.4% 28.50 US$284,950
2004-05-17 2004-05-17 S Sale
GARRETT J STEVEN

Senior VP Clinical Research
2,000 -15.5%
27.02
US$54,030 		2,000 -15.5% 27.02 US$54,030
2004-05-10 2004-05-05 S Sale
BETHUNE DAVID R

Chief Executive Officer

Executive Director
10,000 -6.4%
31.16
US$311,620 		10,000 -6.4% 31.16 US$311,620
2004-04-19 2004-04-16 S Sale GARRETT J STEVEN

Sr VP Clincal Research

Officer
2,000 -13.4%
29.26
US$58,520 		2,000 -13.4% 29.26 US$58,520
2004-04-06 2004-04-05 S Sale BETHUNE DAVID R

Chairman and CEO

Executive Director
10,000 -6.4%
26.34
US$263,410 		10,000 -6.4% 26.34 US$263,410
2004-03-22 2004-03-19 B Purchase VUTURO GEORGE J Non-Executive Director
10,000 +61.2%
24.53
US$245,300 		10,000 +61.2% 24.53 US$245,300
2004-03-22 2004-03-19 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
900 -81.8%
24.80
US$22,320 		900 -81.8% 24.80 US$22,320
2004-03-22 2004-03-19 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
500 -31.2%
25.00
US$12,500 		500 -31.2% 25.00 US$12,500
2004-03-17 2004-03-16 S Sale GARRETT J STEVEN

Sr VP Clinical Research

Officer
1,500 -10.4%
24.26
US$36,390 		1,500 -10.4% 24.26 US$36,390
2004-03-17 2004-03-15 S Sale YARBOROUGH CODY L

VP Dermatology Division

Officer
500 -71.4%
25.23
US$12,615 		500 -71.4% 25.23 US$12,615
2004-02-19 2004-02-17 S Sale YARBOROUGH CODY L

VP Dermatology Division
500 -71.4%
26.90
US$13,450 		500 -71.4% 26.90 US$13,450
2004-02-19 2004-02-17 S Sale GARRETT J STEVEN

Sr VP Clinical Research
2,000 -12.2%
26.90
US$53,800 		2,000 -12.2% 26.90 US$53,800
2004-01-20 2004-01-16 S Sale GARRETT J STEVEN

Senior VP Clinical Research

Officer
2,000 -10.9%
25.05
US$50,100 		2,000 -10.9% 25.05 US$50,100
Explore more

More insider trading research around Tolmar Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America